全文获取类型
收费全文 | 349752篇 |
免费 | 46432篇 |
国内免费 | 2977篇 |
专业分类
耳鼻咽喉 | 7176篇 |
儿科学 | 10589篇 |
妇产科学 | 6523篇 |
基础医学 | 29833篇 |
口腔科学 | 5917篇 |
临床医学 | 45280篇 |
内科学 | 88762篇 |
皮肤病学 | 10013篇 |
神经病学 | 34206篇 |
特种医学 | 12970篇 |
外国民族医学 | 13篇 |
外科学 | 71487篇 |
综合类 | 3632篇 |
现状与发展 | 74篇 |
一般理论 | 291篇 |
预防医学 | 25546篇 |
眼科学 | 7572篇 |
药学 | 15194篇 |
1篇 | |
中国医学 | 380篇 |
肿瘤学 | 23702篇 |
出版年
2023年 | 5343篇 |
2022年 | 2216篇 |
2021年 | 6304篇 |
2020年 | 7821篇 |
2019年 | 5398篇 |
2018年 | 10961篇 |
2017年 | 10205篇 |
2016年 | 11374篇 |
2015年 | 12072篇 |
2014年 | 20870篇 |
2013年 | 23625篇 |
2012年 | 18192篇 |
2011年 | 19347篇 |
2010年 | 17868篇 |
2009年 | 20786篇 |
2008年 | 18971篇 |
2007年 | 18147篇 |
2006年 | 19999篇 |
2005年 | 17861篇 |
2004年 | 16564篇 |
2003年 | 14713篇 |
2002年 | 14327篇 |
2001年 | 5454篇 |
2000年 | 4297篇 |
1999年 | 5055篇 |
1998年 | 6244篇 |
1997年 | 5684篇 |
1996年 | 5343篇 |
1995年 | 4941篇 |
1994年 | 3574篇 |
1993年 | 3115篇 |
1992年 | 2509篇 |
1991年 | 2462篇 |
1990年 | 2024篇 |
1989年 | 2059篇 |
1988年 | 1964篇 |
1987年 | 1815篇 |
1986年 | 1823篇 |
1985年 | 1743篇 |
1984年 | 2001篇 |
1983年 | 1934篇 |
1982年 | 2285篇 |
1981年 | 2007篇 |
1980年 | 1879篇 |
1979年 | 1088篇 |
1978年 | 1260篇 |
1977年 | 1290篇 |
1976年 | 1046篇 |
1975年 | 945篇 |
1974年 | 871篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
John P. Sundberg Kathleen A. Silva Victoria E. Kennedy John J. Wilson Nicholas E. Gott Beth A. Sundberg Derry C. Roopenian 《Experimental dermatology》2019,28(9):1091-1093
2‐deoxy D‐glucose (2DG) was tested for efficacy in treating alopecia areata using the C3H/HeJ skin graft model. 2DG has proven to be efficacious in treatment of various mouse models of autoimmunity with minimal serious side effects noted. This agent has been shown to normalize abnormally activated T‐cell populations while also preventing cell surface expression of NKG2D; key factors defining alopecia areata disease progression. Daily oral ingestion of 2DG via drinking water to mice with patchy or diffuse alopecia areata for 16 weeks failed to prevent expansion of alopecia or cause regrowth of hair in treated mice. Histologically, there were no differences between treated and control groups. These results indicate that, while 2DG is effective for some autoimmune diseases, it was not efficacious for the cell‐mediated autoimmune mouse disease, alopecia areata. 相似文献
132.
Dane Scantling Robert Kucejko John Williamson Alvaro Galvez Amanda Teichman Ryan Gruner Nicholas Serniak Brendan McCracken 《Injury》2019,50(1):54-60
Background
Most elderly trauma patients suffer blunt head injury and many utilize antithrombotic (AT) medications. The utility of delayed CT-head (D-CTH) in neurologically intact elderly patients using AT who have an intracranial hemorrhage (ICH) on presentation is unknown. We hypothesized that D-CTH would not alter clinical management and aimed to evaluate the role of D-CTH in this population.Methods
A retrospective cohort study was performed. Patients ≥65 years sustaining blunt head injuries from January 2010 to July 2017 were identified using our level 1 trauma center database. AT-patients presenting with ICH who underwent D-CTH were included. Patients with worsened ICH were compared to those with stable to improved ICH on D-CTH. AT-patients were compared to a cohort of non-AT patients. Fisher’s Exact and Mann-Whitney U tests were utilized and a power analysis conducted.Results
137?A?T and 34 non-AT patients were identified. There was no difference in hemorrhage progression or appearance of new ICH. No patient had a change in management from D-CTH in either cohort. AT-patients were slightly older (p?<?0.001), but cohorts were otherwise similar.50 AT-patients with worsened ICH were compared to 87 with stable ICH. There was no difference in cohort demographics. Hemorrhage progression did not vary with type of AT used but did increase if multiple types of synchronous ICH were present (p?<?0.001).Conclusions
Our data supports abstaining from routine D-CTH of elderly ICH patients with an intact neurologic examination who are utilizing aspirin, clopidogrel or warfarin. Conclusions cannot be drawn regarding new oral anticoagulants (NOACs) given low enrollment. Further multicenter study is required to provide adequate power and detect small levels of management change. 相似文献133.
134.
135.
136.
137.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
138.
139.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
140.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310